Keymed Biosciences Inc. (HKG:2162)
73.50
+1.20 (1.66%)
May 7, 2026, 4:08 PM HKT
58.06% (1Y)
| Market Cap | 21.65B +79.2% |
| Revenue (ttm) | 797.12M +67.3% |
| Net Income | -581.60M |
| EPS | -2.12 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | 43.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 909,168 |
| Average Volume | 2,139,180 |
| Open | 72.30 |
| Previous Close | 72.30 |
| Day's Range | 72.30 - 76.05 |
| 52-Week Range | 37.40 - 81.85 |
| Beta | -0.11 |
| RSI | 55.77 |
| Earnings Date | Mar 26, 2026 |